Shinpoong Pharmaceutical Co.,Ltd

A019170

KR7019170000

Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
13,640 ^KRW	+2.10%		+8.51%	+0.89%

Apr. 24	Korean Sugar Imports Plunge 14% as Diabetes Cases Surge	MT
2023	South Korean Shares Continue Losing Streak Amid High Interest Rate Woes	MT

Almac Discovery Ltd licenses ALM201 to Shin Pooong Pharm., Co. Ltd for Development and Marketing in South Korea

April 29, 2013 at 05:11 am EDT

Almac Discovery announced the licensing of its anti-angiogenic peptide ALM201 to Shin Poong Pharmaceutical Company Ltd. for clinical development and marketing in South Korea. Shin Poong will make an undisclosed upfront payment and pay milestones and royalties as part of the deal. The Shin Poong programme in South Korea will run in parallel with Almac Discovery's own development programme in Europe.

Latest news about Shinpoong Pharmaceutical Co.,Ltd

Korean Sugar Imports Plunge 14% as Diabetes Cases Surge	Apr. 24	MT
South Korean Shares Continue Losing Streak Amid High Interest Rate Woes	23-09-25	MT
Financial Regulator Probes Shinpoong Pharmaceutical Employees for Trading Using Undisclosed Information	23-09-25	MT
Shin Poong Pharm.Co.,Ltd.(KOSE:A019170) dropped from FTSE All-World Index	23-09-18	CI
Shin Poong Pharm.Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
MSCI Korea Index Adds Meritz Financial, Meritz Fire & Marine Insurance	22-02-11	MT
Shin Poong Pharm.Co.,Ltd.(KOSE:A019170) added to FTSE All-World Index	21-03-22	CI
Shin Poong Pharm : A (markets) journal of the plague year	20-12-31	RE
Shin Poong Pharm : A (markets) journal of the plague year	20-12-31	RE
A (markets) journal of the plague year	20-12-21	RE
A (markets) journal of the plague year	20-12-20	RE
Shin Poong Pharm.Co.,Ltd.(KOSE:A019170) added to KOSPI 200 Index	20-12-11	CI
Shin Pooong Pharm., Co. Ltd(KOSE:A019170) added to S&P Global BMI Index	15-09-21	CI
Almac Discovery Ltd licenses ALM201 to Shin Pooong Pharm., Co. Ltd for Development and Marketing in South Korea	13-04-29	CI

Chart Shinpoong Pharmaceutical Co.,Ltd

Duration

Period

More charts

Company Profile

Shin Pooong Pharm., Co. Ltd is a Korea-based company mainly engaged in the manufacture of pharmaceuticals. The Company's product portfolio consists of antibiotics, cardiovascular drugs, anti-cancer drugs, psychoneurotic drugs, antirheumatic drugs, antidiabetics, antifungal agents, antihistamines, antiviral agents, benign prostatic hyperplasia (BPH) drugs and trichogens. The Company also provides active pharmaceutical ingredients (APIs) synthesized by the Company, including non-steroidal anti-inflammatory drugs (NSAIDs), cardiovascular drugs, anti-ulcer drugs, respiratory drugs, antispasmodics drugs and others. The Company distributes its products within domestic market and to overseas markets.

Sector

Pharmaceuticals

Calendar

2024-05-12 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
SHINPOONG PHARMACEUTICAL CO.,LTD	+0.89%	523M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+19.62%	43.34B
OTSUKA HOLDINGS CO., LTD.	+20.44%	21.96B
SANDOZ GROUP AG	+10.86%	14.09B
CIPLA LIMITED	+13.07%	13.64B
ZYDUS LIFESCIENCES LIMITED	+37.46%	11.43B
ONO PHARMACEUTICAL CO., LTD.	-8.59%	6.86B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+8.46%	5.22B